Article Information
PubMed
Print ISSN
Online ISSN
History
- Received October 9, 2002
- Accepted January 22, 2003
- Published online May 1, 2003.
Article Versions
- Earlier version (January 24, 2003 - 15:02).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Lawrence H. Lash1,
- Ronald N. Hines2,
- Frank J. Gonzalez3,
- Timothy R. Zacharewski4 and
- Mark A. Rothstein5
- 1Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan (L.H.L.); 2Birth Defects Research Center, Departments of Pediatrics and Pharmacology/Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin (R.N.H.); 3Laboratory of Metabolism, National Cancer Institute, Bethesda, Maryland (F.J.G.); 4Department of Biochemistry and Molecular Biology, National Food Safety and Toxicology Center, Michigan State University, East Lansing, Michigan (T.R.Z.); and 5Institute for Bioethics, Health Policy and Law, University of Louisville School of Medicine, Louisville, Kentucky (M.A.R.)
- Dr. Lawrence H. Lash, Department of Pharmacology, Wayne State University School of Medicine, 540 East Canfield Avenue, Detroit, Michigan 48201. E-mail:l.h.lash{at}wayne.edu
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
- Article
- Abstract
- Pharmacogenetics and Susceptibility to Toxic Chemicals: Historical Perspective, Current Status and Future Challenges
- Use of Gene Knockout and Transgenic Mice to Study the Roles of Xenobiotic-Metabolizing Enzymes in Toxicology
- Gene Expression Profiling in Mechanistic and Predictive Toxicology
- Ethical and Legal Implications of Pharmacogenetics
- Conclusions
- Footnotes
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement